Glioblastoma — Trials

Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

1,750 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 486
Recruiting: 258
Ph III recruiting: 13
Growth YoY: +41%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (281)

clinicaltrialsPublishedShowing 301–350 of 543 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02586857	A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)	active not recruiting	Phase 1 / Phase 2	24	Acerta Pharma BVINDUSTRY	1	Mar 25, 2026	clinicaltrials
NCT04574856	Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma	active not recruiting	Phase 2	30	University of Michigan Rogel Cancer CenterOTHER	1	Mar 25, 2026